Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...

Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...

ON24 , a leading intelligent engagement platform for B2B sales and marketing, today announced it has achieved top rankings across multiple enterprise categories in the G2 Winter 2025 Reports.

The SIP Forum is proud to announce that the official agenda and webinar registrations are now live for the BRANDED CALLING SUMMIT, a special virtual event focused on the exciting new breed of Branded ...

New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with Disopyramide<br ...

Sprunki Phase 3 Remastered is a fan-driven reimagining of the iconic Incredibox series, blending rhythm-based gameplay with spine-chilling horror aesthetics. Developed by VTLC and released in late ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal ...

The U.S. Environmental Protection Agency (EPA) is reviewing several key emissions regulations that could impact the trucking ...